Stay updated on INEC: Irradiation and Nivolumab in Esophageal Cancer Clinical Trial
Sign up to get notified when there's something new on the INEC: Irradiation and Nivolumab in Esophageal Cancer Clinical Trial page.

Latest updates to the INEC: Irradiation and Nivolumab in Esophageal Cancer Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoNo Change Detected
- Check18 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.1%
- Check25 days agoNo Change Detected
- Check32 days agoChange DetectedThe webpage has been updated to reflect a new study on Nivolumab and radiotherapy for esophageal cancer, including a change in the study's design and collaborators. The previous detailed description of the study's cohorts and inclusion/exclusion criteria has been significantly condensed.SummaryDifference37%
- Check39 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.1%
- Check47 days agoChange DetectedThe web page has been updated from version 2.14.2 to version 2.14.3.SummaryDifference0.1%
- Check82 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference1%
- Check97 days agoChange DetectedThe web page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference1%
Stay in the know with updates to INEC: Irradiation and Nivolumab in Esophageal Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the INEC: Irradiation and Nivolumab in Esophageal Cancer Clinical Trial page.